Agios Pharmaceuticals (AGIO) Pension (2012 - 2013)
Agios Pharmaceuticals (AGIO) reported Pension of $6000.0 for Q4 2013, down 60.0% on a YoY basis from $15000.0 in Q4 2012, and down 40.0% quarter-over-quarter from $10000.0 in Q2 2013.
Agios Pharmaceuticals (AGIO) Pension (2012 - 2013) Analysis & Trends
Agios Pharmaceuticals has reported Pension for 2 years, with the latest figure at $6000.0 in Q4 2013.
- For the quarter ending Q4 2013, Pension fell 60.0% year-over-year to $6000.0; the trailing twelve-month figure through Dec 2013 stood at $6000.0 (down 60.0% YoY), and the FY2013 full-year result was $6000.0, down 60.0% from the prior year.
- Pension for Q4 2013 stood at $6000.0, down from $10000.0 in the prior quarter.
- The five-year high for Pension was $15000.0 in Q4 2012, with the low at $6000.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Agios Pharmaceuticals | 2.01 Bn | 2.01 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 6,000.00 |
| Jun 30, 2013 | 10,000.00 |
| Dec 31, 2012 | 15,000.00 |